Enhanced surveillance is generally recommended for individuals with a higher risk of cancer due to genetic predisposition, family history, previous cancer diagnosis, or exposure to carcinogens. For example, individuals with BRCA1 or BRCA2 mutations may undergo more frequent breast and ovarian cancer screenings.
